Donaco International Limited engages in leisure and entertainment businesses in the Asia Pacific region.
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$0.034|
|52 Week High||AU$0.029|
|52 Week Low||AU$0.092|
|1 Month Change||0%|
|3 Month Change||-12.82%|
|1 Year Change||9.68%|
|3 Year Change||-80.57%|
|5 Year Change||-92.84%|
|Change since IPO||-92.09%|
Recent News & Updates
Robust Earnings May Not Tell The Whole Story For Donaco International (ASX:DNA)
Donaco International Limited's ( ASX:DNA ) healthy profit numbers didn't contain any surprises for investors. We...
Is Donaco International (ASX:DNA) A Risky Investment?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
How Much Did Donaco International's(ASX:DNA) Shareholders Earn From Share Price Movements Over The Last Five Years?
It is a pleasure to report that the Donaco International Limited ( ASX:DNA ) is up 78% in the last quarter. But will...
|DNA||AU Hospitality||AU Market|
Return vs Industry: DNA underperformed the Australian Hospitality industry which returned 47.2% over the past year.
Return vs Market: DNA underperformed the Australian Market which returned 24.4% over the past year.
Stable Share Price: DNA is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 11% a week.
Volatility Over Time: DNA's weekly volatility (11%) has been stable over the past year.
About the Company
|1990||n/a||Techatut Sukcharoenkraisri Huy||https://www.donacointernational.com|
Donaco International Limited engages in leisure and entertainment businesses in the Asia Pacific region. It operates Star Vegas Resort & Club, a casino and hotel complex comprising approximately 150 gaming tables, 1,000 slot machines, and 385 hotel rooms in Poipet, Cambodia; and Aristo International Hotel, a boutique casino comprising 400 hotel rooms in northern Vietnam located on the border with Yunnan Province, China. The company was incorporated in 1990 and is based in Sydney, Australia.
Donaco International Fundamentals Summary
|DNA fundamental statistics|
Is DNA overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|DNA income statement (TTM)|
|Cost of Revenue||AU$7.20m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||0.02|
|Net Profit Margin||243.98%|
How did DNA perform over the long term?See historical performance and comparison
Is Donaco International undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate DNA's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate DNA's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: DNA is good value based on its PE Ratio (1.7x) compared to the Australian Hospitality industry average (35.3x).
PE vs Market: DNA is good value based on its PE Ratio (1.7x) compared to the Australian market (19.1x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate DNA's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: DNA is good value based on its PB Ratio (0.3x) compared to the AU Hospitality industry average (3.7x).
How is Donaco International forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Consumer Services industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Donaco International has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Donaco International performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: DNA has a large one-off gain of A$42.5M impacting its June 30 2021 financial results.
Growing Profit Margin: DNA became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: DNA has become profitable over the past 5 years, growing earnings by -25.2% per year.
Accelerating Growth: DNA has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: DNA has become profitable in the last year, making it difficult to compare its past year earnings growth to the Hospitality industry (4.2%).
Return on Equity
High ROE: DNA's Return on Equity (15.3%) is considered low.
How is Donaco International's financial position?
Financial Position Analysis
Short Term Liabilities: DNA's short term assets (A$8.6M) do not cover its short term liabilities (A$28.7M).
Long Term Liabilities: DNA's short term assets (A$8.6M) exceed its long term liabilities (A$7.7M).
Debt to Equity History and Analysis
Debt Level: DNA's debt to equity ratio (6.8%) is considered satisfactory.
Reducing Debt: DNA's debt to equity ratio has reduced from 31.6% to 6.8% over the past 5 years.
Debt Coverage: DNA's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if DNA's interest payments on its debt are well covered by EBIT.
What is Donaco International current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate DNA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate DNA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if DNA's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if DNA's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: DNA is not paying a notable dividend for the Australian market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of DNA's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Techatut Sukcharoenkraisri Huy
Mr. Lee Bug Huy, also known as Techatut Sukcharoenkraisri, serves as Chief Executive Officer and Executive Director at Donaco International Limited since September 03, 2020. He was Non-Executive Director a...
CEO Compensation Analysis
Compensation vs Market: Insufficient data to establish whether Techatut Sukcharoenkraisri's total compensation is reasonable compared to companies of similar size in the Australian market.
Compensation vs Earnings: Techatut Sukcharoenkraisri's compensation has been consistent with company performance over the past year.
Experienced Management: DNA's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.
Experienced Board: DNA's board of directors are not considered experienced ( 1 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Donaco International Limited's employee growth, exchange listings and data sources
- Name: Donaco International Limited
- Ticker: DNA
- Exchange: ASX
- Founded: 1990
- Industry: Casinos and Gaming
- Sector: Consumer Services
- Market Cap: AU$42.003m
- Shares outstanding: 1.24b
- Website: https://www.donacointernational.com
- Donaco International Limited
- 25 Martin Place
- Level 43
- New South Wales
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/09/26 08:05|
|End of Day Share Price||2021/09/24 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.